Worldwide Network for Blood and Marrow Transplantation recommendations for establishing a Hematopoietic Cell Transplantation Program, Part I: minimum requirements and beyond
File(s)WorldwideNetworkForBloodAndMarrow.pdf (342.21 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Hematopoietic cell transplantation (HCT) is a highly complex procedure that requires a dedicated multidisciplinary team to optimize safety. In addition, institutions may have different needs regarding indications based on regional disease prevalence or may have an interest in developing specialized services. Structured recommendations are not commonly available, however. The Transplant Center and Recipient Issues Standing Committee of the Worldwide Network for Blood and Marrow Transplantation (WBMT) organized a structured review of all pertinent elements for establishing a transplantation program. First, we solicited components from committee members and grouped them into domains (infrastructure, staff, cell processing laboratory, blood banking, laboratory, radiology, pharmacy, HLA testing, ancillary services, and quality). Subsequently, reviewers scored each element on a 7-point scale, ranging from an absolute requirement (score of 1) to not required (score of 7). An independent group of 5 experienced transplantation physicians reviewed the rankings. The minimum requirements for establishing any HCT program were identified among elements with mean score of ≤2.0, and specific elements for allogeneic and autologous HCT were identified. Mean scores of >2.0 to 4.0 were classified as preferred recommendation, and mean scores of >4.0 to ≤ 7.0 were considered ideal recommendations for advanced and complex types of transplantation. This structured set of recommendations guides the prioritization of minimum requirements to establish a transplantation program and set the stage for expansion and further development.
Date Issued
2019-12
Date Acceptance
2019-05-01
Citation
Biology of Blood and Marrow Transplantation, 2019, 25 (12), pp.2322-2329
ISSN
1083-8791
Publisher
Elsevier
Start Page
2322
End Page
2329
Journal / Book Title
Biology of Blood and Marrow Transplantation
Volume
25
Issue
12
Copyright Statement
© 2019 The Author(s). Published by Elsevier Ltd. on behalf of King Faisal Specialist Hospital & Research Centre and Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy. This is an open access article under the CC BY-NC-ND license. (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/31071457
PII: S1083-8791(19)30286-1
Subjects
Autologous versus allogeneic transplantation
Transplantation program requirements
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2019-05-06